<DOC>
	<DOCNO>NCT02260791</DOCNO>
	<brief_summary>The purpose study compare effectiveness safety FKB327 comparison Humira® rheumatoid arthritis patient inadequate disease control methotrexate .</brief_summary>
	<brief_title>A Study Compare FKB327 Efficacy Safety With Humira® Rheumatoid Arthritis Patients</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>1 . Male female age 18 year 2 . Patients diagnose Rheumatoid Arthritis ( RA ) least 3 month 3 . Patient active RA 4 . Patient take stable dose methotrexate least 3 month 1 . Patient previously treat adalimumab 2 . Patient previously treat ongoing treatment prohibit medication 3 . Patient immunise live attenuated vaccine past 4 week 4 . Patient positive result HIV , HBV , HCV TB infection Other Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Rheumatoid</keyword>
	<keyword>Arthritis</keyword>
</DOC>